Search details
1.
Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy.
J Neuroinflammation
; 14(1): 58, 2017 03 20.
Article
in English
| MEDLINE | ID: mdl-28320438
2.
[An atypical case of lipoid proteinosis]. / Un cas atypique de protéinose lipoïde.
Ann Pathol
; 37(5): 425-428, 2017 Oct.
Article
in French
| MEDLINE | ID: mdl-28935411
3.
Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2-dependent prostaglandin E2 in human dendritic cells.
Blood
; 122(8): 1419-27, 2013 Aug 22.
Article
in English
| MEDLINE | ID: mdl-23847198
4.
Chronic inflammatory demyelinating polyradiculoneuropathy: search for factors associated with treatment dependence or successful withdrawal.
J Neurol Neurosurg Psychiatry
; 85(8): 901-6, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-24309269
5.
Intravenous immunoglobulin exerts reciprocal regulation of Th1/Th17 cells and regulatory T cells in Guillain-Barré syndrome patients.
Immunol Res
; 60(2-3): 320-9, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-25391612
6.
Peripheral neuropathies in rheumatic disease--a guide to diagnosis.
Nat Rev Rheumatol
; 8(10): 599-609, 2012 Oct.
Article
in English
| MEDLINE | ID: mdl-22907292
7.
Intravenous immunoglobulin-mediated expansion of regulatory T cells in autoimmune patients is associated with increased prostaglandin E2 levels in the circulation.
Cell Mol Immunol
; 12(5): 650-2, 2015 Sep.
Article
in English
| MEDLINE | ID: mdl-25482074
Results
1 -
7
de 7
1
Next >
>>